SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing a massive, momentum-driven rally fueled by renewed market interest in clean energy infrastructure, specifically regarding the scaling of fuel cell technology for AI-driven data centers. While some community members celebrate the price appreciation, others are voicing skepticism based on the company's long-term history of dilution and previous reverse splits, creating a sharp divide between retail bulls expecting a breakout similar to industry peers and wary bears calling for a pullback.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is gaining momentum as investors eye potential M&A activity, with community discussion highlighting rumors of a buyout and the company's strategic pivot toward capital efficiency. The sentiment is fueled by heavy call option volume and signs of short covering, as the stock attempts to clear key resistance levels.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is trending as investors react to a strong quarterly earnings report that highlighted record revenue growth driven by significant demand for AI infrastructure and integrated memory solutions. The community is actively debating the company's long-term sustainability due to its heavy reliance on AI spending, upcoming share dilution, and concerns about potential margin compression as memory market conditions evolve.

T1 Energy, Inc. engages in providing energy solutions focused on solar module and solar cell manufacturing. It focuses on building an integrated U.S. supply chain for solar and batteries. The company was founded by Tom Einar Jensen, Peter Matrai, and Tore Ivar Slettemoen on August 31, 2023 and is headquartered in Austin, TX.

T1 Energy Inc.

T1 Energy is seeing significant volatility driven by intense retail community interest and active debates over the company's long-term solar manufacturing thesis versus short-seller allegations. Investors are closely monitoring key technical support levels and awaiting updates on facility funding, while many maintain a long-term bullish outlook tied to AI data center energy demand.

Immix Biopharma, Inc. operates as a biopharmaceutical company that engages in the development of therapies for cancer and inflammatory diseases. The company was founded by Ilya Rachman, Sean Senn, and Vladimir Torchilin in 2012 and is headquartered in Los Angeles, CA.

Immix Biopharma Inc

IMMX is generating significant momentum as institutional accumulation continues ahead of anticipated BLA filings and upcoming clinical milestones. Investors are closely tracking its Breakthrough Therapy Designation for NXC-201 and potential M&A interest within the rare disease space, driving active discussions regarding the stock's valuation upside and institutional sentiment.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is trending as investors focus on the company's progress with its lead asset atacicept following its recent FDA approval for IgA Nephropathy. Community sentiment remains mixed, with some retail investors expressing frustration over muted post-approval price action, while others highlight the potential for long-term growth and acquisition interest given the company's strong cash position and clinical milestone.

Canadian Solar, Inc. engages in the manufacture of solar photovoltaic modules, provision of solar energy and battery storage solutions, and development of utility-scale solar and battery storage products. It operates through the CSI Solar and Global Energy segments. The CSI Solar segment designs, develops, and manufactures solar ingots, wafers, cells, modules, and other solar power and battery storage products. The Global Energy segment includes solar and battery storage project development and sale, asset management services for operational projects, sale of electricity, and investment in retained assets. The company was founded by Shawn Qu in October 2001 and is headquartered in Kitchener, Canada.

Canadian Solar Inc

Canadian Solar is experiencing significant investor attention as market participants weigh a leadership transition at its Recurrent Energy arm against the company's long-term potential to benefit from the growing AI-driven demand for power. While community members remain divided over the company's debt levels and its historical share price performance, the ongoing pivot toward U.S.-based manufacturing and energy storage is fueling debate over whether the stock is an undervalued play on the future energy stack.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is gaining significant momentum as investors bet on the company's GLP-1 obesity pipeline, with community members actively discussing a potential breakout toward new highs. The stock is being closely monitored for a potential short squeeze as participants weigh the strength of its metabolic pipeline against the prospect of future M&A activity.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is facing significant volatility and market pressure due to a patent infringement lawsuit from Wolfspeed and broader sector rotation away from high-beta AI infrastructure plays. While community sentiment remains polarized, many investors are focused on the company's long-term potential in GaN and SiC power technology as they look for stabilization near key technical support levels.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is trending as investors digest the commercial launch of NEREUS for motion sickness while speculating on a potential buyout, with many in the community debating the stock's low valuation and the firm's aggressive regulatory stance. Traders remain closely focused on the company's clinical pipeline, specifically the upcoming Phase 3 trial for GLP-1 related nausea, amidst active community discussions regarding persistent price volatility and institutional accumulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$FTAI LOL 272 to 230.  AI can&#39;t run on jet fuel kidz.  See you at 50.   Too bad I&#39;m only short... (checks notes).. 10 shares.

spliffmeister

StockTwits Web

FTAI Aviation Ltd

 LOL 272 to 230.  AI can't run on jet fuel kidz.  See you at 50.   Too bad I'm only short... (checks notes).. 10 shares.